BlackRock’s MedTech Acquisition Corporation Unit MTACU Stock Holding History
Bought
Maintained
Sold
Other funds holding MTACU
MF
HP
DM
DCP
IM
MP
PVI
VI
MA
BlackRock's MTACU Position: Q1 2021 in Review
BlackRock sold out of MedTech Acquisition Corporation Unit (MTACU) in Q1 2021, closing a stake of 2,750,000 shares — an estimated $28.9M sold.
BlackRock first reported a position in MTACU in Q4 2020 and held it in 1 quarter. The position peaked at $28.9M in Q4 2020. 31 funds tracked by Wall St. Rank hold MTACU as of Q1 2021.
- BlackRock reported no remaining MedTech Acquisition Corporation Unit position as of Q1 2021 after selling out during the quarter.
- BlackRock sold 2,750,000 MedTech Acquisition Corporation Unit shares in Q1 2021, an estimated $28.9M.
- BlackRock first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 1 quarter.
- BlackRock's MedTech Acquisition Corporation Unit position peaked at $28.9M in Q4 2020.
- 31 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q1 2021.
Based on BlackRock's 13F filing for Q1 2021, filed 7 May 2021.